[1]
Klotz, U. 2005. Reassessment of the benefit/risk-ratio of selective COX-2-inhibitors. Swiss Medical Weekly. 135, 1112 (Mar. 2005), 166–166. DOI:https://doi.org/10.4414/smw.2005.11057.